T1	Outcomes 454 513	safety, tolerability, pharmacokinetics and pharmacodynamics
T2	Outcomes 847 887	Minimal treatment-related adverse events
T3	Outcomes 919 943	Serum interferon (IFN)-Î±
T4	Outcomes 1231 1289	Induction of chemokines/cytokines and IFN-stimulated genes
T5	Outcomes 1435 1470	safety and pharmacodynamic activity